Short Interest in DICE Therapeutics, Inc. (NASDAQ:DICE) Declines By 10.7%

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 4,360,000 shares, a decrease of 10.7% from the July 15th total of 4,880,000 shares. Approximately 10.4% of the company’s stock are short sold. […]

Related Keywords

Ohio ,United States ,Northpond ,Johnr Jacobsen , ,Northpond Ventures Gp Llc ,Wells Fargo Company ,Cantor Fitzgerald ,Therapeutics Company Profile ,Therapeutics Inc ,Dice Therapeutics Inc ,Vestcor Inc ,Securities Exchange Commission ,Gamco Investors ,Nasdaq ,Get Free Report ,Exchange Commission ,Employees Retirement System ,Dice Therapeutics ,Nasdaq Dice ,Dice ,Medical ,Stocks ,Options ,Put ,Call ,